Search Results - "SAKAI, Tatsunori"
-
1
Feasibility of an intensified myeloablative conditioning regimen consisting of busulfan, fludarabine, cytarabine, and total body irradiation before single cord blood transplantation in elderly patients
Published in International journal of hematology (01-07-2021)“…The optimal conditioning regimen for stem cell transplantation in elderly patients remains to be established. We developed a novel preparative regimen using…”
Get full text
Journal Article -
2
A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer
Published in Scientific reports (30-05-2024)“…Nanoliposomal irinotecan with fluorouracil and folinic acid (NFF) is a standard regimen after gemcitabine-based therapy for patients with unresectable or…”
Get full text
Journal Article -
3
Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel
Published in Scientific reports (23-07-2024)“…This study aimed to compare second-line treatment outcomes for patients with unresectable pancreatic cancer previously treated with gemcitabine plus…”
Get full text
Journal Article -
4
A phase II study of bortezomib in patients with relapsed or refractory aggressive adult T‐cell leukemia/lymphoma
Published in Cancer science (01-09-2015)“…Adult T‐cell leukemia/lymphoma (ATL) is a malignancy of peripheral T‐lymphocytes with a poor prognosis. This multicenter, two‐stage, single‐arm, phase II study…”
Get full text
Journal Article -
5
Elderly ATL patients in ageing society of Japan
Published in Retrovirology (06-06-2011)Get full text
Journal Article -
6
MO7-4 Impact of biliary drainage for pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil and folinic acid
Published in Annals of oncology (01-11-2023)Get full text
Journal Article -
7
MO61-6 Efficacy of third-line chemotherapy after liposomal irinotecan and fluorouracil with folinic acid for pancreatic cancer
Published in Annals of oncology (01-11-2023)Get full text
Journal Article -
8
Efficacy and safety of nanoliposomal irinotecan plus fluorouracil and folinic acid after irinotecan-based chemotherapy in patients with advanced pancreatic cancer: Results of the retrospective part of the NAPOLEON-2 study
Published in Journal of clinical oncology (01-02-2023)“…705 Background: Nanoliposomal irinotecan plus fluorouracil and folinic acid (nal-IRI/FU/LV; NFF) is the standard regimen after gemcitabine-based therapy for…”
Get full text
Journal Article -
9
Multicenter observational study of nanoliposomal irinotecan and fluorouracil/leucovorin in patients with unresectable or recurrent pancreatic cancer (NAPOLEON-2): Final retrospective results
Published in Journal of clinical oncology (01-02-2023)“…706 Background: Nanoliposomal irinotecan (NAL-IRI) and fluorouracil with folinic acid (NFF) is the standard regimen after gemcitabine-based therapy for…”
Get full text
Journal Article -
10
Serum sickness induced by rituximab infusion; report of two cases with hematological malignancies
Published in Rinshō ketsueki (01-04-2009)“…We report 2 cases of serum sickness after rituximab infusion. Case 1 is a patient with Waldenström's macroglobulinemia, and case 2 is a patient with…”
Get more information
Journal Article -
11
Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever
Published in Mycoses (01-08-2020)“…Summary Background Fungal infections are a major complication of neutropaenia following chemotherapy. Their early diagnosis is difficult, and empirical…”
Get full text
Journal Article -
12
Primary mediastinal malignant teratoma with leukemic conversion
Published in Nihon Naika Gakkai zasshi (10-06-2007)Get more information
Journal Article -
13
Identification of aberrantly methylated genes in association with adult T-cell leukemia
Published in Cancer research (Chicago, Ill.) (01-09-2004)“…In this study, we identified 53 aberrantly hypermethylated DNA sequences in adult T-cell leukemia (ATL) cells using methylated CpG island…”
Get full text
Journal Article -
14
Missense mutation of the interleukin-12 receptor β1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection
Published in Blood (01-05-2001)Get full text
Journal Article -
15
Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor κB ligand on adult T-cell leukemia cells
Published in Blood (15-01-2002)“…Hypercalcemia is one of the most frequent and serious complications in patients with adult T-cell leukemia (ATL) and is due to marked bone resorption by…”
Get full text
Journal Article -
16
Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia
Published in Cancer research (Chicago, Ill.) (15-02-2000)“…In this study, we examined the methylation status of the CDKN2A gene in patients with different forms of adult T-cell leukemia (ATL) using Southern blot…”
Get full text
Journal Article -
17
Impaired production of naive T lymphocytes in human T-cell leukemia virus type I–infected individuals: its implications in the immunodeficient state
Published in Blood (15-05-2001)“…Opportunistic infections frequently occur in patients with adult T-cell leukemia (ATL) and human T-cell leukemia virus type I (HTLV-I) carriers. However, the…”
Get full text
Journal Article -
18
A Potential Link between Alternative Splicing of the NBS1 Gene and DNA Damage/Environmental Stress
Published in Radiation research (01-07-2008)“…Takai, K., Sakamoto, S., Sakai, T., Yasunaga, J., Komatsu, K. and Matsuoka, M. A Potential Link between Alternative Splicing of the NBS1 Gene and DNA…”
Get full text
Journal Article -
19
Allogeneic Hematopoietic Stem Cell Transplantation as Consolidation Therapy for Adult T Cell Leukemia/Lymphoma Patients: A Single-Center Experience in 35 Patients
Published in Blood (16-11-2007)“…Adult T cell leukemia/lymphoma (ATL) has a high incident in Japanese. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) against ATL made the…”
Get full text
Journal Article -
20
Addition of Rituximab Improves Progression-Free and Overall Survival in Patients with B-Cell Lymphoma Receiving Doxorubicin-Containing Chemotherapy
Published in Blood (16-11-2007)“…Background: Many clinical trials have documented the efficacy of rituximab in B-cell lymphomas. However, it remains unclear whether rituximab will improve…”
Get full text
Journal Article